ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Addressing Vertebral Osteoporosis Incidentally Detected to Prevent Future Fractures (AVOID Fracture)

This study is currently recruiting participants.
Verified by University of Alberta, June 2008

Sponsors and Collaborators: University of Alberta
Canadian Institutes of Health Research (CIHR)
Information provided by: University of Alberta
ClinicalTrials.gov Identifier: NCT00388908
  Purpose

Osteoporosis is a common and progressive condition that leads to broken bones (fractures), which cause pain, disability, deformity, and even death. There are new treatments available that can decrease the risk of a fracture by 50%, and the people who benefit the most are those with osteoporosis who have already had a fracture, like a vertebral (spine) fracture. Vertebral fractures are usually "silent," and ~20% of people over the age of 60 years have had one although they don't know it. Many of these people have had chest x-rays done for other reasons, and these x-rays can incidentally detect these silent fractures. Although most people with a vertebral fracture should be tested and treated for osteoporosis, studies demonstrate that less than one-quarter of older people with a vertebral fracture are ever investigated or even treated. This reflects a gap between evidence-based best practice and everyday practice in the community. The proposed research addresses this care-gap by using a quality improvement intervention that uses chest x-rays done in the Emergency Department to remind family physicians about osteoporosis while providing them with evidence-based treatment guidelines - with or without educating and empowering patients about osteoporosis. The effectiveness of this intervention will be compared to usual care in a controlled trial. The intent of this research is to improve quality of care for patients at high risk of fracture, by increasing rates of testing and treatment of osteoporosis.


Condition Intervention
Osteoporosis
Behavioral: Reminders and opinion leader generated guidelines +/- leaflets and counselling
Other: Usual Care

MedlinePlus related topics:   Fractures    Osteoporosis    X-Rays   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Prevention, Non-Randomized, Double Blind (Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:   Addressing Vertebral Osteoporosis Incidentally Detected to Prevent Future Fractures: The AVOID FRACTURE Study

Further study details as provided by University of Alberta:

Primary Outcome Measures:
  • The primary outcome is the proportion of patients starting prescription osteoporosis treatment within 3 months of fracture recognition [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Secondary outcomes include BMD testing, diagnosis of osteoporosis, knowledge, and quality of life. [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Estimated Enrollment:   240
Study Start Date:   November 2006
Estimated Study Completion Date:   May 2010
Estimated Primary Completion Date:   November 2009 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
A: Experimental
Multifaceted intervention
Behavioral: Reminders and opinion leader generated guidelines +/- leaflets and counselling
B: Active Comparator
Usual Care
Other: Usual Care

Show detailed description  Show Detailed Description

  Eligibility
Ages Eligible for Study:   60 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • age 60 years or greater
  • chest radiograph that reports the presence of a vertebral fracture
  • discharged home.

Exclusion Criteria:

  • unable to provide simple informed consent or unwilling to participate in the study
  • unable to read, understand, and converse in English
  • admitted to hospital
  • currently enrolled in the pilot study or other osteoporosis-related studies
  • currently taking any prescription osteoporosis treatment
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00388908

Contacts
Contact: Sumit R. Majumdar, MD, MPH     780-407-1399     me2.majumdar@ualberta.ca    
Contact: Brian H. Rowe, MD, MSc     780-407-1399     brian.rowe@ualberta.ca    

Locations
Canada, Alberta
University of Alberta Hospital     Recruiting
      Edmonton, Alberta, Canada, T6G 2B7
      Contact: Debbie Bellerose, RN     780-407-3930     dbellerose@cha.ab.ca    
      Contact: Sumit R. Majumdar, MD, MPH     780-407-1399     me2.majumdar@ualberta.ca    

Sponsors and Collaborators
University of Alberta
Canadian Institutes of Health Research (CIHR)

Investigators
Principal Investigator:     Sumit R. Majumdar, MD, MPH     University of Alberta    
  More Information

Responsible Party:   University of Alberta ( Sumit R. Majumdar )
Study ID Numbers:   CIHR-MOP-79325
First Received:   October 16, 2006
Last Updated:   June 19, 2008
ClinicalTrials.gov Identifier:   NCT00388908
Health Authority:   Canada: Health Canada

Keywords provided by University of Alberta:
vertebral fractures  
osteoporosis  
prevention  
case-finding  
quality improvement  

Study placed in the following topic categories:
Signs and Symptoms
Musculoskeletal Diseases
Fractures, Bone
Spinal Fractures
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers